Lectures
Department Meeting - 580006 SE Pharma Lectures (2026S)
The Pharma Lecture series is part of the department's seminar program. The lecture series focuses on current topics in pharmaceutical and nutritional sciences, as well as related fields. Invited national and international experts give engaging presentations. Lectures take place on Thursdays at 11:30 a.m in lecture hall (HS) 6. See below for the complete schedule of the current semester.
Schedule summer term 2026
|
Date |
Location |
Lecturer |
Lecture Title |
Host |
|---|---|---|---|---|
|
25.06.2026 |
HS 6 |
Prof.Dr. Lina Jankauskaitė; Institute of Physiology and Pharmacology, Lithuanian University of Health Sciences, Kaunas, Lithuania |
Rare Diseases: the Frontline of Innovation in Pharmacy |
Anna Weinzinger |
|
11.06.2026 |
HS 6 |
Ass.Prof. Lorenzo Albertazzi, PhD; Institute for Complex Molecular Systems, Eindhoven University of Technology, The Netherlands |
Understanding targeted (nano)medicine one molecule at the time, with super-resolution microscopy |
Christoph Rademacher |
|
07.05.2026 |
HS 6 |
Prof.Dr. Peter Kolb; Institute of Pharmaceutical Chemistry, Univ. of Marburg, Germany |
Looking at the finer details of small molecule: GPCR interactions |
Sabine Glasl-Tazreiter |
|
23.04.2026 |
HS 6 |
Priv.Doz.Dr. Mariana Spetea; Institute of Pharmaceutical Chemistry, Univ. of Innsbruck |
From classical opioids to safer therapeutics: new concepts in opioid drug discovery |
Johannes Kirchmair |
|
16.04.2026 |
HS 6 |
Dr. Sabine Öttl/Dr. Michael Oberhuber, Laimburg Research Centre, South Tyrol |
Research with Practical Impact: How Laimburg Research Centre is innovating the Agrifood sector in South Tyrol |
Judith Rollinger |
|
26.03.2026 |
HS 6 |
Ass.Prof. Dr. Natalia Khuri, Department of Computer Science, Wake Forest University, USA |
Hidden Players in Drug Absorption: Excipients, Transporters, and the Gut Microbiome |
Gerhard Ecker |
|
05.03.2026 |
HS 6 |
Ass.Prof. David E. Heppner, PhD; Dept. of Chemistry, Univ. of Buffalo, USA |
Structure-forward Studies of EGFR Inhibitors and Their Impact on Drug Discovery |
David B. Konrad |